View Author

Heremans, H.

( H. Heremans)


t cells le-mtppe le-mtppe /ifn immunomodulator treatment survival immunomodulation defense macrophage liposomal immunomodulators depletion pneumoniae spleen production liposomal activation host defense potentiation injection 103 cfu host defense control infection effect cd 8 cells antimicrobial host defense 2 cells septicemia 4 days 20 mice immunol le-ifn murine antibody cd 8-positive cells t-cell galactosidase mab group antimicrobial interferon -10 1 cells inoculation nk cells expression study il -10 rabbit igg immunocompetent mice van vianen immunocompetent cytokine rat igg 2b klebsiella pneumoniae septicemia activity il -4 rabbit t-cell subsets flow cytometry level cd 4- augmentation administration stimulation experiment muramyl antigen liposomes potentiation t-helper type 1 spleen cells host defense augmentation response killer cell anti-cd tripeptide mouse rat igg 2a murine tnf 100 g le-mtppe / ifn




1 Most Recent Publications

Involvement of T cells in enhanced resistance to Klebsiella pneumoniae septicemia in mice treated with liposome-encapsulated muramyl tripeptide phosphatidylethanolamine or gamma interferon (Article)
Hagen, T.L.M. ten Vianen, W. van Savelkoul, H.F.J. Heremans, H. Buurman, W.A. Bakker-Woudenberg, I.A.J.M.
1998-01-01